Takeda is a global, research-driven Japanese biopharmaceutical leader focused on developing and delivering innovative medicines, with key areas including Oncology, Gastroenterology, Neuroscience, Rare Diseases, Plasma-Derived Therapies, and Vaccines. The company was founded in 1971 and is today among the top 10 largest pharmaceutical companies in the world. The company has nearly 50,000 employees worldwide.
Role in the project
Takeda follows science and aims to unlock innovation wherever it originates through partnerships and investments in digital technologies. We believe IHI project BRIDGE brings unprecedented opportunity to create a regulatory sandbox framework in a multi-stakeholder manner so that the medical innovation reaches the patient quicker. We will contribute as members in WP2 and WP3 and provide our insights and experience to overall project deliverables.